CASPR has proposed a new model for GLP-1 based harm reduction, called GRACE: GLP-1 Rapid Access Care for Opoid Use Disorder.
A description of the model is in our publication, Recursive Adapation: GRACE: Proposing a new GLP-1 based harm reduction strategy